PharmaBoardroom

Top 10 Vaccine Companies Globally

Vaccines are back on top of the pharma priority list as companies race against the clock to develop the first effective COVID-19 vaccine. Below we…

Key Challenges for Life Sciences & Healthcare in 2020:…

‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…

Peter L. Saltonstall – President & CEO, National…

Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what…

Skyepharma’s David Lescuyer on Manufacturing & Supply…

David Lescuyer, managing director of fully integrated French CDMO Skyepharma, outlines how the COVID-19 crisis could usher in a new era for the…

Five Cell & Gene Companies to Know in Europe

The cell and gene therapy market was valued at USD 6 billion in 2017 and is projected to exceed USD 35 billion in value by 2026. Moreover, these…

COVID-19 and the Brazilian Pharma Supply Chain

The editorial team at Panorama Farmaceutico explain how the COVID-19 pandemic and global trade flow stoppages are impacting the manufacture and supply…

Pharma Faces: Constanza Losada, Pfizer Mexico

Pfizer, one of the world’s largest pharmaceutical companies, has been active in Mexico since 1951, and has been led in Mexico by Argentinean…

EFPIA’s Nathalie Moll on COVID-19 & the Future of…

In a recent exclusive conversation with PharmaBoardroom, Nathalie Moll, director general of the European Federation of Pharmaceutical Industries &…

New CEO for Ipsen as David Loew Makes Switch From Sanofi Pasteur

David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…